(a) Contracting activities which have been designated as Reinvention Laboratories may grant individual or class deviations to the FAR, DFARS, or DLAD, where necessary to accomplish reinvention laboratory initiatives. This authority may be delegated by the HCA, without power of redelegation, to the chief of the contracting office. The Director, Acquisition Management, (J-7) has delegated this authority to the Commander of the Defense Reutilization and Marketing Service (DRMS) and the Administrator of the Defense National Stockpile Center (DNSC) without power of redelegation.
(b) This deviation authority does not apply to:
(i) Deviations which have a significant effect beyond internal operating procedures or; those which have a significant cost or administrative impact on contractors or offerors (see FAR 1.501).
(ii) Individual deviations at DFARS 201.402(1)(i) which require Director, Defense Procurement and Acquisition Policy approval.
(iii) Requirements imposed by statute or that implement regulations or directives of other agencies.
(c) Reporting Requirement. A report covering all deviations exercised as a result of the Reinvention Laboratories initiative shall be forwarded to J-71 15 days after the end of each calendar quarter. Reports shall contain a brief description of any deviation exercised as a result of this authority including the FAR, DFARS, or DLAD citation, the action or class to which the deviation applies, and the goal which the deviation supports. The Executive Director Acquisition Management , will consolidate and submit to the Director, Defense Procurement and Acquisition Policy a quarterly report with a brief description of all deviations exercised in the last quarter.
